Деменция с острым началом при COVID-19
Рекомендуемое оформление библиографической ссылки:
Пищикова Л.Е., Летникова З.В., Егорова Д.А. Деменция с острым началом при COVID-19 // Российский психиатрический журнал. 2023. №1. С. 60-68.
С целью определения способности вируса COVID-19 вызывать когнитивные нарушения и деменцию у людей старшего возраста проанализирован клинический случай развития деменции с острым началом. Представлен обзор факторов патогенеза, способных обусловить развитие когнитивной дисфункции, среди которых – непосредственное воздействие вируса на структуры головного мозга, гипоксия, тромбоз, нарушения мозгового кровообращения. Проведена историческая параллель с экзогенными типами реакций K. Bonhoeffer. Приведены результаты исследований психопатологических проявлений гриппозных психозов в прошлом, не утративших свою актуальность до настоящего времени. Отмечена особая роль формы нарушенного сознания, характерной для инфекционных и соматических психозов – аменции. Описана последовательная смена экзогенных типов реакций, приведшая к деменции.
Ключевые слова люди старшего возраста; экзогенные типы реакций; K. Bonhoeffer; нейротропность вируса COVID-19; расстройства сознания; аменция; деменция с острым началом; психические расстройства при эпидемиях гриппа в историческом контексте
1. Otchet Pensionnogo fonda Rossii za 2021 god. URL: https://sfr.gov.ru/files/id/press_center/godovoi_otchet/Godovoy_otchet_PFR_-_2021.pdf (accessed on: 01.11.2022). (In Russ.) 2. Tanaka T, Okamoto S. Increase in suicide following an initial decline during the COVID-19 pandemic in Japan. Nat Hum Behav. 2021;5(2):229–38. DOI: https://doi.org/10.1038/s41562-020-01042-z 3. Mosolov SN. Problemy psikhicheskogo zdorov’ya v usloviyakh pandemii COVID-19. Zh Nevrol Psikhiatr Im SS Korsakova. 2020;120(5):7–15. (In Russ.) DOI: https://doi.org/10.17116/jnevro20201200517 4. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34–9. DOI: https://doi.org/10.1016/j.bbi.2020.04.027 5. Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing. The need for prevention and early intervention. JAMA Intern Med. 2020;180(6):817–8. DOI: https://doi.org/10.1001/jamainternmed.2020.1562 6. Bannikov GS, Milekhina AV, Pishchikova LE. Suicidal'noe povedenie v usloviyah pandemii COVID-19. Informacionnoe pis'mo. Moscow; 2021. 15 p. (In Russ.) 7. Alemanno F, Houdayer E, Parma A, et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021;16(2):e0246590. DOI: https://doi.org/10.1371/journal.pone.0246590 8. Jaywant A, Vanderlind WM, Alexopoulos GS, et al. Frequency and Profile of Objective Cognitive Deficits in Hospitalized Patients Recovering from COVID-19. Neuropsychopharmacology. 2021;46(13):2235–40. DOI: https://doi.org/10.1038/s41386-021-00978-8 9. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611–27. DOI: https://doi.org/10.1016/S2215-0366(20)30203-0 10. Mosolov SN. Dlitel'nye psihicheskie narusheniya posle perenesennoj ostroj koronavirusnoj infekcii SARS-CoV-2. Sovremennaya terapiya psihicheskih rasstrojstv. 2021;(3):2–23. (In Russ.) DOI: https://doi.org/10.21265/PSYPH.2021.31.25.001 11. Mazza MG, de Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594–600. DOI: https://doi.org/10.1016/j.bbi.2020.07.037 12. Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27. DOI: https://doi.org/10.1016/S2215-0366(21)00084-5 13. Beaud V, Crottaz-Herbette S, Dunet V, et al. Pattern of cognitive deficits in severe COVID-19. J Neurol Neurosurg Psychiatry. 2021;92(5):567–8. DOI: https://doi.org/10.1136/jnnp-2020-325173 14. Bonhoeffer K. Die symptomatischen Psychosen im Gufolge von akuten Infektionen und inneren Erkrankungen. Leipzig; Wien; 1910. 139 p. 15. Snezhnevskij AV. Pozdnie simptomaticheskie psihozy. Trudy Nevropsihiatricheskogo instituta im. P.B. Gannushkina. Moscow; 1940. Vol. 5. p. 156–275. (In Russ.) 16. Korsakov SS. K voprosu ob ostryh formah umopomeshatel'stva. Moscow; 1891. 12 p. (In Russ.) 17. Postovskij NP. Nervnye i dushevnye zabolevaniya pri inflyuence: Klinika. Obshhaja patologija. Lechenie. Doktorskaya dissertaciya. Moscow; 1904. 400 p. (In Russ.) 18. Naku AG. O psihozah pri epidemii grippa, vyzvannoj virusom A 2 v 1957 i 1959 godah. Infekcionnye psihozy. Trudy Kishinevskogo medicinskogo instituta. Vol. XV. Kishinev; 1961. p. 17–26. (In Russ.) 19. Gulyamov MG. Levinson YA. K. K ucheniyu o grippoznyh psihozah. Trudy Stalinabadskogo gosudarstvennogo medicinskogo instituta. 1959. Vol. 40, No 1. p. 75–108. (In Russ.) 20. Kahana TB. K voprosu o grippoznom encefalite. Infekcionnye psihozy. Trudy Kishinevskogo medicinskogo instituta. Vol. XV. Kishinev; 1961. р. 27–35. (In Russ.) 21. Molohov AN. Ob amencii i ee etiologicheskih variantah. Infekcionnye psihozy. Trudy Kishinevskogo medicinskogo instituta. Vol. XV. Kishinev; 1961. р. 125–33. (In Russ.) 22. Belopasov VV, Yachou Y, Samoilova EM, Baklaushev VP. The Nervous System Damage in COVID-19. Klinicheskaja praktika. 2020;11(2):60–80. (In Russ.) DOI: https://doi.org/10.17816/clinpract34851 23. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130–40. DOI: https://doi.org/10.1016/S2215-0366(20)30462-4 24. Nakamura ZM, Nash RP, Laughon SL, Rosenstein DL. Neuropsychiatric Complications of COVID-19. Curr Psychiatry Reports. 2021;23(5):23–5. DOI: https://doi.org/10.1007/s11920-021-01237-9 25. Premraj L, Kannapadi NV, Briggs J. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434:120162. DOI: https://doi.org/10.1016/j.jns.2022.120162 26. La Hue SC, James TC., Newman JC, et al. Collaborative Delirium Prevention in the Age of COVID-19. J Am Geriatr Soc. 2020;68(5):947–9. DOI: https://doi.org/10.1111/jgs.16480.214 27. Misra S, Kolappa K, Prasad M. Frequency of Neurologic Manifestations in COVID-19: A Systematic Review and Meta-analysis. Neurology. 2021;97(23):e2269–81. DOI: https://doi.org/10.1212/WNL.0000000000012930 28. Reichard RR, Kashani KB, Boire NA, et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1–6. DOI: https://doi.org/10.1007/s00401-020-02166-2 29. Mao L, Jin H, Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1–9. DOI: https://doi.org/10.1001/jamaneurol.2020.1127 30. Ellul MA., Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767–83. DOI: https://doi.org/10.1016/S1474-4422(20)30221-0 31. Kotfis K, Marra A, Ely EW. ICU delirium – a diagnostic and therapeutic challenge in the intensive care unit. Anaesthesiol Intensive Ther. 2018;50(2):160–7. DOI: https://doi.org/10.5603/AIT.a2018.0011 32. Alonso-Lana S, Marquie M, Ruiz A, Boada M. Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia. Front Aging Neurosci. 2020;12:588872. DOI: https://doi.org/10.3389/fnagi.2020.588872 33. Almeria M, Cejudo JC, Sotoca J, et al. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health. 2020;9:100163. DOI: https://doi.org/10.1016/j.bbih.2020.100163 34. Luo W, Liu X, Bao K, Huang C. Ischemic stroke associated with COVID-19: a systematic review and meta-analysis. J Neurol. 2022;269(4):1731–40. DOI: https://doi.org/10.1007/s00415-021-10837-7 35. Pizova NV, Pizov NA, Skachkova OA, et al. [Acute Cerebral Circulatory Disorders and Coronavirus Disease]. Meditsinskiy sovet [Medical Council]. 2020;(8):18–25. (In Russ.) DOI: https://doi.org/10.21518/2079-701X-2020-8-18-25 36. Varatharaj A, Thomas N, Ellul MA, et al. Neurological and Neuropsychiatric Complications of COVID-19 in 153 Patients: A UK-Wide Surveillance Study. Lancet Psychiatry. 2020;7(10):875–82. DOI: https://doi.org/10.1016/S2215-0366(20)30287-X 37. Pendlebury ST, Rothwell PM. Incidence and Prevalence of Dementia Associated with Transient Ischaemic Attack and Stroke: Analysis of the Population-Based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248–58. DOI: https://doi.org/10.1016/S1474-4422(18)30442-3 38. Mijajlović MD, Pavlović A, Brainin M, et al. Post-Stroke Dementia – A Comprehensive Review. BMC Med. 2017;15(1):11. DOI: https://doi.org/10.1186/s12916-017-0779-7 39. SHirokov EA. COVID-associirovannyj ishemicheskij insul't. Klinicheskaya medicina. 2020;98(5):375–7. (In Russ.) DOI: http://doi.org/10.30629/0023-2149-2020-98-5-375-377 40. Palmer JC, Tayler HM, Love S. Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. J Alzheimers Dis. 2013;36(3):577–87. DOI: https://doi.org/10.3233/JAD-13038
Метрики статей
Metrics powered by PLOS ALM